Day 1: Top Takeaways From ASCO26
In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302 study in urothelial carcinoma, a potential new treatment option for patients with PD-L1-positive advanced non–small cell lung cancer, and a novel psychosocial digital application that improves fatigue and distress in patients with multiple myeloma.
LINK TO FULL TRANSCRIPT
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.